A Study of SHR-A1904 in Patients With Advanced Solid Cancer
Clinical trial NCT04877717 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04877717
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-01
- Primary completion
- 2025-12-01
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.